Aug 11, 2020
CNS Pharmaceuticals to Provide Second Quarter 2020 Business Update on Thursday, August 13, 2020
Jun 11, 2020
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
Jun 09, 2020
CNS Announces Highlights from Annual Meeting of Shareholders
May 27, 2020
CNS Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020
May 27, 2020
CNS Provides Update on Development Agreement for WP1122
May 18, 2020
CNS Announces Nasdaq Trading Halt Pending Receipt of Additional Information
May 11, 2020
CNS Provides Additional Comments Regarding Trading Halt
May 08, 2020
Investor Alert: Kaplan Fox Investigates CNS Pharmaceuticals
May 04, 2020
CNS Pharmaceuticals Announces Trading Halt
Apr 23, 2020
CNS Pharmaceuticals Announces Filing of FDA Orphan Drug Designation for Brain Cancer Drug Berubicin
Apr 22, 2020
CNS Pharmaceuticals to Host Shareholder Webinar Today to Discuss Coronavirus Collaboration, the Significance of WP1244, and an Update on the Cancer Free Survivor Treated with Berubicin
Apr 15, 2020
CNS Pharmaceuticals Announces Shareholder Webinar to Discuss Collaboration with WPD Pharmaceuticals for Developing Coronavirus Drug Candidates, the Significance of WP1244, and an Update on the Cancer Free Survivor Treated with Berubicin
Apr 13, 2020
CNS Pharmaceuticals Announces Independent University Research Confirms Active Compound in WP1122 Completely Prevents Coronavirus Replication In Vitro; WP1122 is Subject to Development Agreement with WPD Pharmaceuticals
Mar 23, 2020
CNS Pharmaceuticals Signs Agreement with WPD Pharmaceuticals to Develop Drug Candidates for a Range of Viruses including Coronavirus for International Markets
Mar 12, 2020
CNS Pharmaceuticals Announces Business Highlights and 2019 Fourth Quarter Financial Results
Mar 05, 2020
CNS Pharmaceuticals to Report Fourth Quarter 2019 Financial Results on March 12, 2020
Mar 03, 2020
CNS Pharmaceuticals Announces Brain Cancer Patient from Berubicin Phase 1 Trial Remains Cancer Free
Feb 27, 2020
CNS Pharmaceuticals to Ring Nasdaq Stock Market Opening Bell on March 3
Feb 04, 2020
CNS Pharmaceuticals Announces Completion of GMP Manufacturing
Jan 28, 2020
CNS Pharmaceuticals Completes Pilot Manufacturing Steps Pursuant to FDA Pre-IND Guidance